REG-BARCLAYS PLC FORM 8.3 - NORTONLIFELOCK INC.
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220110:nBwhWdfla&default-theme=true
FORM 8.3 - NORTONLIFELOCK INC.
FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
Rule 8.3 of the Takeover Code (the “Code”)
1. KEY INFORMATION
(a) Full name of discloser: Barclays PLC.
(b) Owner or controller of interest and short
positions disclosed, if different from 1(a):
(c) Name of offeror/offeree in relation to whose NORTONLIFELOCK INC
relevant securities this form relates:
(d) If an exempt fund manager connected with an
offeror/offeree, state this and specify identity of
offeror/offeree:
(e) Date position held/dealing undertaken: 07 January 2022
(f) In addition to the company in 1(c) above, is the discloser making YES:
disclosures in respect of any other party to the offer? AVAST PLC
2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE
If there are positions or rights to subscribe to disclose in more than one
class of relevant securities of the offeror or offeree named in 1(c), copy
table 2(a) or (b) (as appropriate) for each additional class of relevant
security.
(a) Interests and short positions in the relevant securities of the offeror or
offeree to which the disclosure relates following the dealing (if any)
Class of relevant security: USD 0.01 common
Interests Short Positions
Number (%) Number (%)
(1) Relevant securities owned
and/or controlled: 1,339,959 0.23% 552,610 0.09%
(2) Cash-settled derivatives:
274,830 0.05% 1,513,170 0.26%
(3) Stock-settled derivatives (including options)
and agreements to purchase/sell: 0 0.00% 2,100 0.00%
(4)
TOTAL: 1,614,789 0.28% 2,067,880 0.36%
Class of relevant security: Convertible Bond US668771AA66
Interests Short Positions
Number (%) Number (%)
(1) Relevant securities owned
and/or controlled: 390,000 0.07% 0 0.00%
(2) Cash-settled derivatives:
0 0.00% 0 0.00%
(3) Stock-settled derivatives (including options)
and agreements to purchase/sell: 0 0.00% 0 0.00%
(4)
TOTAL: 390,000 0.07% 0 0.00%
All interests and all short positions should be disclosed.
Details of any open stock-settled derivative positions (including traded
options), or agreements to purchase or sell relevant securities, should be
given on a Supplemental Form 8 (Open Positions).
(b) Rights to subscribe for new securities (including directors’ and other
employee options)
Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:
3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE
Where there have been dealings in more than one class of relevant securities
of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as
appropriate) for each additional class of relevant security dealt in.
The currency of all prices and other monetary amounts should be stated.
(a) Purchases and sales
Class of relevant Purchase/sale Number of Price per unit
security securities
USD 0.01 common Purchase 24 26.6750 USD
USD 0.01 common Purchase 24 26.6950 USD
USD 0.01 common Purchase 29 26.6900 USD
USD 0.01 common Purchase 51 26.6429 USD
USD 0.01 common Purchase 70 26.7650 USD
USD 0.01 common Purchase 124 26.6700 USD
USD 0.01 common Purchase 192 27.0600 USD
USD 0.01 common Purchase 300 26.7700 USD
USD 0.01 common Purchase 300 26.8666 USD
USD 0.01 common Purchase 400 26.7100 USD
USD 0.01 common Purchase 504 26.6712 USD
USD 0.01 common Purchase 515 26.8021 USD
USD 0.01 common Purchase 600 26.6800 USD
USD 0.01 common Purchase 730 26.8183 USD
USD 0.01 common Purchase 747 26.6681 USD
USD 0.01 common Purchase 815 26.7166 USD
USD 0.01 common Purchase 2,176 26.8317 USD
USD 0.01 common Purchase 2,760 26.7582 USD
USD 0.01 common Purchase 3,792 26.7934 USD
USD 0.01 common Purchase 4,308 26.7533 USD
USD 0.01 common Purchase 12,407 26.6072 USD
USD 0.01 common Purchase 13,501 26.7372 USD
USD 0.01 common Purchase 15,982 26.7470 USD
USD 0.01 common Purchase 22,567 26.7512 USD
USD 0.01 common Purchase 46,287 26.6100 USD
USD 0.01 common Purchase 65,214 26.7027 USD
USD 0.01 common Sale 4 26.8300 USD
USD 0.01 common Sale 4 27.1450 USD
USD 0.01 common Sale 12 26.6950 USD
USD 0.01 common Sale 19 26.6550 USD
USD 0.01 common Sale 38 26.6775 USD
USD 0.01 common Sale 42 26.7080 USD
USD 0.01 common Sale 48 26.6900 USD
USD 0.01 common Sale 57 26.6766 USD
USD 0.01 common Sale 57 26.6883 USD
USD 0.01 common Sale 57 26.6750 USD
USD 0.01 common Sale 70 26.7650 USD
USD 0.01 common Sale 100 26.8650 USD
USD 0.01 common Sale 100 26.5950 USD
USD 0.01 common Sale 120 26.7408 USD
USD 0.01 common Sale 123 26.6646 USD
USD 0.01 common Sale 138 26.6850 USD
USD 0.01 common Sale 159 26.6294 USD
USD 0.01 common Sale 174 26.7050 USD
USD 0.01 common Sale 200 26.7625 USD
USD 0.01 common Sale 200 26.8600 USD
USD 0.01 common Sale 215 26.5986 USD
USD 0.01 common Sale 233 26.6963 USD
USD 0.01 common Sale 274 26.5958 USD
USD 0.01 common Sale 324 26.9033 USD
USD 0.01 common Sale 340 26.7385 USD
USD 0.01 common Sale 400 26.7262 USD
USD 0.01 common Sale 419 26.7100 USD
USD 0.01 common Sale 487 26.6979 USD
USD 0.01 common Sale 676 26.6800 USD
USD 0.01 common Sale 788 26.7539 USD
USD 0.01 common Sale 921 26.6045 USD
USD 0.01 common Sale 1,863 26.7492 USD
USD 0.01 common Sale 3,127 26.6157 USD
USD 0.01 common Sale 3,796 26.7938 USD
USD 0.01 common Sale 5,005 26.7380 USD
USD 0.01 common Sale 5,536 26.7399 USD
USD 0.01 common Sale 10,404 26.7509 USD
USD 0.01 common Sale 10,807 26.6072 USD
USD 0.01 common Sale 11,009 26.7540 USD
USD 0.01 common Sale 18,315 26.7516 USD
USD 0.01 common Sale 47,095 26.6100 USD
USD 0.01 common Sale 71,600 26.7142 USD
(b) Cash-settled derivative transactions
Class of relevant security Product description Nature of dealing Number of reference securities Price per unit
e.g. CFD e.g. opening/closing a long/short position, increasing/reducing a long/short
position
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or varying
Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type Expiry date Option money paid/ received per unit
e.g. American, European etc.
(ii) Exercise
Class of relevant security Product description Exercising/ exercised against Number of securities Exercise price per unit
e.g. call option
(d) Other dealings (including subscribing for new securities)
Class of relevant security Nature of dealing Details Price per unit (if applicable)
e.g. subscription, conversion
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any agreement or
understanding, formal or informal, relating to relevant securities which may
be an inducement to deal or refrain from dealing entered into by the person
making the disclosure and any party to the offer or any person acting in
concert with a party to the offer:
Irrevocable commitments and letters of intent should not be included. If there
are no such agreements, arrangements or understandings, state “none”
None
(b) Agreements, arrangements or understandings relating to options or
derivatives
Details of any agreement, arrangement or understanding, formal or informal,
between the person making the disclosure and any other person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant
securities to which any derivative is referenced:
If there are no such agreements, arrangements or understandings, state
“none”
None
(c) Attachments
Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure: 10 Jan 2022
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
Public disclosures under Rule 8 of the Code must be made to a Regulatory
Information Service.
The Panel’s Market Surveillance Unit is available for consultation in
relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.
*If the discloser is a natural person, a telephone number does not need to be
included, provided contact information has been provided to the Panel’s
Market Surveillance Unit.
The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk
(https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.thetakeoverpanel.org.uk%2F&esheet=52559551&newsitemid=20220110005521&lan=en-US&anchor=www.thetakeoverpanel.org.uk&index=1&md5=7d56828e553d7dfe6c3dc778501c5772)
.
SUPPLEMENTAL FORM 8 (OPEN POSITIONS)
DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING OPTION) POSITIONS,
AGREEMENTS TO PURCHASE OR SELL ETC.
Note 5(i) on Rule 8 of the Takeover Code (the “Code”)
1. KEY INFORMATION
Identity of the person whose positions/dealings Barclays PLC.
are being disclosed:
Name of offeror/offeree in relation to whose NORTONLIFELOCK INC
relevant securities this from relates:
2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)
Class Product Writing, Number Exercise Type Expiry
of description purchasing, of price date
relevant selling, securities per unit
security varying etc to which
option
relates
USD 0.01 common Put Options Purchased -2,100 30.0000 American 21 Jan 2022
3. AGREEMENTS TO PURCHASE OR SELL ETC.
Full details should be given so that the nature of the interest or position
can be fully understood:
It is not necessary to provide details on a Supplemental Form (Open Positions)
with regard to cash-settled derivatives.
The currency of all prices and other monetary amounts should be stated.
The Panel’s Market Surveillance Unit is available for consultation in
relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.
The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk
(https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.thetakeoverpanel.org.uk%2F&esheet=52559551&newsitemid=20220110005521&lan=en-US&anchor=www.thetakeoverpanel.org.uk&index=2&md5=39147e6961147b9b1b204de722ba65f1)
View source version on businesswire.com:
https://www.businesswire.com/news/home/20220110005521/en/
(https://www.businesswire.com/news/home/20220110005521/en/)
BARCLAYS PLC
Copyright Business Wire 2022Recent news on Barclays
See all newsREG - Barclays PLC NCC Group PLC - Form 8.3 NCC GROUP PLC
AnnouncementREG - Barclays PLC Spire Healthcare Grp - Form 8.3 SPIRE HEALTHCARE GROUP PLC
AnnouncementREG - Barclays PLC Intnl Personal Fin - Form 8.3 INTERNATIONAL PERSONAL FINANCE PLC
AnnouncementREG - Barclays PLC Intertek Group Plc - Form 8.3 INTERTEK GROUP PLC
AnnouncementREG - Barclays PLC Life Science REIT - Form 8.3 LIFE SCIENCE REIT PLC
Announcement